Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Giglio Group SpA (GGTV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.4170 +0.0180    +4.51%
03/05 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Italy
ISIN:  IT0005122400 
  • Volume: 1,004
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.4170 - 0.4190
Giglio Group SpA 0.4170 +0.0180 +4.51%

GGTV Recent Sentiments

 
This page contains information on users’ sentiments for the Giglio Group SpA stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 02, 2024 Michele Fasulo   0.4160 +0.24%
Apr 29, 2024 stefano dellacqua   0.3970 -5.04%
Apr 15, 2024 Ok Ok   0.4190 -0.48%
Apr 10, 2024 Michele Fasulo   0.3940 Apr 12, 2024 @ 0.3990 +1.27%
Apr 10, 2024 Fulvio Croce   0.3890 May 03, 2024 @ 0.4170 -7.20%
Apr 02, 2024 Gabriele Grimoldi   0.4170 Apr 26, 2024 @ 0.3820 -8.39%
Mar 28, 2024 Michele Fasulo   0.3990 Apr 03, 2024 @ 0.4100 +2.76%
Feb 22, 2024 Michele Fasulo   0.4390 Mar 15, 2024 @ 0.4240 -3.42%
Feb 21, 2024 Giancarlo Dari   0.4430 Feb 26, 2024 @ 0.4190 -5.42%
Feb 16, 2024 Giancarlo Dari   0.4400 Feb 19, 2024 @ 0.4400 0.00%
Feb 16, 2024 Michele Fasulo   0.4400 Feb 20, 2024 @ 0.4470 +1.59%
Feb 09, 2024 Michele Fasulo   0.4300 Feb 13, 2024 @ 0.4370 +1.63%
Feb 06, 2024 Michele Fasulo   0.4490 Feb 09, 2024 @ 0.4500 +0.22%
Jan 31, 2024 domenico rossi   0.4540 Feb 05, 2024 @ 0.4460 -1.76%
Jan 22, 2024 Ok Ok   0.4610 Feb 16, 2024 @ 0.4400 -4.56%
Jan 18, 2024 STENO6791 .   0.4800 Feb 09, 2024 @ 0.4200 -12.50%
Jan 10, 2024 Michele Fasulo   0.4870 Jan 26, 2024 @ 0.4480 -8.01%
Dec 21, 2023 alek Martini   0.4750 Jan 12, 2024 @ 0.4730 +0.42%
Dec 06, 2023 Michele Fasulo   0.5260 Dec 29, 2023 @ 0.4830 -8.17%
Dec 06, 2023 Ok Ok   0.5260 Dec 29, 2023 @ 0.4830 -8.17%
Dec 01, 2023 Michele Fasulo   0.4900 Dec 06, 2023 @ 0.5260 +7.35%
Nov 07, 2023 Marco Screti   0.5420 Nov 30, 2023 @ 0.4760 -12.18%
Nov 02, 2023 Elisabetta Giribaldi   0.5200 Nov 30, 2023 @ 0.4760 +8.46%
Oct 31, 2023 domenico rossi   0.4240 Nov 01, 2023 @ 0.4520 +6.60%
Oct 10, 2023 Virgilio Sponta   0.5660 Nov 30, 2023 @ 0.4760 -15.90%
Sep 19, 2023 Max Galimi   0.5700 Nov 30, 2023 @ 0.4760 +16.49%
Sep 18, 2023 Renato Reposo   0.5800 Nov 30, 2023 @ 0.4760 -17.93%
Sep 15, 2023 Gabriele Grimoldi   0.6420 Nov 30, 2023 @ 0.4760 -25.86%
Aug 21, 2023 Franco Castelli   0.6620 Nov 30, 2023 @ 0.4760 -28.10%
Aug 08, 2023 Nicola Nicola   0.6100 Nov 30, 2023 @ 0.4760 +21.97%
Jul 28, 2023 Cristian Bonora   0.6200 Nov 30, 2023 @ 0.4760 -23.23%
Jul 05, 2023 Ok Ok   0.6920 Nov 30, 2023 @ 0.4760 -31.21%
Jun 30, 2023 Michele Fasulo   0.7020 Nov 30, 2023 @ 0.4760 -32.19%
Jun 08, 2023 elvio ma   0.8200 Nov 30, 2023 @ 0.4760 -41.95%
Jun 06, 2023 ri si   0.8280 Nov 30, 2023 @ 0.4760 -42.51%
Jun 05, 2023 Gianni Vincenzi   0.8400 Nov 30, 2023 @ 0.4760 -43.33%
Jun 02, 2023 Antonio Mancini   0.8300 Nov 30, 2023 @ 0.4760 -42.65%
May 30, 2023 Andrea Santarelli   0.7400 Nov 30, 2023 @ 0.4760 -35.68%
May 29, 2023 Enzo Amato   0.7480 Nov 30, 2023 @ 0.4760 -36.36%
May 24, 2023 Michele Fasulo   0.7520 Jun 01, 2023 @ 0.8400 +11.70%
May 23, 2023 Gaetano Guarino   0.7600 Nov 30, 2023 @ 0.4760 +37.37%
May 22, 2023 Antonio Mancini   0.7840 May 31, 2023 @ 0.7400 -5.61%
May 22, 2023 Roberto Corti   0.7000 Jun 15, 2023 @ 0.8520 +21.71%
May 19, 2023 Michele Fasulo   0.6080 May 23, 2023 @ 0.7560 +24.34%
May 15, 2023 Gaetano Santaniello   0.6240 Jun 02, 2023 @ 0.8320 +33.33%
May 12, 2023 Antonio Panipucci   0.6600 Nov 30, 2023 @ 0.4760 +27.88%
May 11, 2023 Gabriele Arienti   0.7220 Nov 30, 2023 @ 0.4760 +34.07%
May 11, 2023 Andrea De Paola   0.7200 Nov 30, 2023 @ 0.4760 -33.89%
May 10, 2023 Angelo Galizzi   0.7800 Nov 30, 2023 @ 0.4760 -38.97%
May 08, 2023 Carlo Cameran   0.7880 Jun 22, 2023 @ 0.7980 +1.27%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GGTV Comments

Write your thoughts about Giglio Group SpA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lorenzo De Santis
Lorenzo De Santis Dec 12, 2021 7:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Società inaffidabile e Soci non affidabili. Pura speculazione. Conto economico e asset societari in crisi. Sinacnsiglia di investire in Giglio Group.
Giov Cl
Giov Cl Jul 16, 2020 11:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
giglio.com/brooks-brothers/
Giov Cl
Giov Cl Jul 15, 2020 6:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Coronavirus vaccine update: GSK all set to develop a plant-based vaccine; China's Sinopharm has started Phase-3 trials of COVID-vaccineTIMESOFINDIA.COM | Last updated on - Jul 15, 2020, 11:37 IST
Giov Cl
Giov Cl Jul 14, 2020 7:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
"Four of the Chinese candidates in human trials are inactivated vaccines, including Sinovac's and two vaccines from China National Biotec Group (CNBG), a unit of state-owned China National Pharmaceutical Group (Sinopharm)."
Giov Cl
Giov Cl Jul 14, 2020 7:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
livemint.com/news/world/coronavirus-vaccine-china-leads-in-race-with-two-vaccines-in-final-testing-11594128303626.html
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email